Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1982 1
1989 1
2000 1
2002 2
2003 2
2005 1
2006 1
2007 3
2008 1
2009 7
2010 3
2011 1
2013 3
2014 7
2015 3
2016 2
2017 7
2018 8
2019 6
2020 7
2021 6
2022 10
2023 12
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Rhino-orbital-cerebral Mucormycosis.
Niculae CM, Craciun L. Niculae CM, et al. Among authors: craciun l. N Engl J Med. 2024 Mar 21;390(12):e30. doi: 10.1056/NEJMicm2309352. Epub 2024 Mar 16. N Engl J Med. 2024. PMID: 38502066 No abstract available.
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.
Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K. Noël G, et al. Among authors: craciun l. J Clin Invest. 2021 Oct 1;131(19):e139905. doi: 10.1172/JCI139905. J Clin Invest. 2021. PMID: 34411002 Free PMC article.
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Buisseret L, et al. Among authors: craciun l. Nat Commun. 2023 Nov 2;14(1):7018. doi: 10.1038/s41467-023-42744-y. Nat Commun. 2023. PMID: 37919269 Free PMC article. Clinical Trial.
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.
Wang X, Venet D, Lifrange F, Larsimont D, Rediti M, Stenbeck L, Dupont F, Rouas G, Garcia AJ, Craciun L, Buisseret L, Ignatiadis M, Carausu M, Bhalla N, Masarapu Y, Villacampa EG, Franzén L, Saarenpää S, Kvastad L, Thrane K, Lundeberg J, Rothé F, Sotiriou C. Wang X, et al. Among authors: craciun l. Nat Commun. 2024 Nov 26;15(1):10232. doi: 10.1038/s41467-024-54145-w. Nat Commun. 2024. PMID: 39592577 Free PMC article.
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM, Raspé E, Coulonval K, Decaussin-Petrucci M, Tarabichi M, Dom G, Libert F, Craciun L, Andry G, Wicquart L, Leteurtre E, Trésallet C, Marlow LA, Copland JA, Durante C, Maenhaut C, Cavaco BM, Dumont JE, Costante G, Roger PP. Pita JM, et al. Among authors: craciun l. Front Endocrinol (Lausanne). 2023 Oct 26;14:1247542. doi: 10.3389/fendo.2023.1247542. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37964967 Free PMC article.
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial.
De Caluwe A, Romano E, Poortmans P, Gombos A, Agostinetto E, Marta GN, Denis Z, Drisis S, Vandekerkhove C, Desmet A, Philippson C, Craciun L, Veys I, Larsimont D, Paesmans M, Van Gestel D, Salgado R, Sotiriou C, Piccart-Gebhart M, Ignatiadis M, Buisseret L. De Caluwe A, et al. Among authors: craciun l. J Immunother Cancer. 2023 Dec 6;11(12):e007279. doi: 10.1136/jitc-2023-007279. J Immunother Cancer. 2023. PMID: 38056900 Free PMC article. Clinical Trial.
Role of copper during microglial inflammation.
Craciun L, Muroy SE, Saijo K. Craciun L, et al. bioRxiv [Preprint]. 2024 Sep 19:2024.09.18.613750. doi: 10.1101/2024.09.18.613750. bioRxiv. 2024. PMID: 39345477 Free PMC article. Preprint.
Thyroid cancer under the scope of emerging technologies.
Tarabichi M, Demetter P, Craciun L, Maenhaut C, Detours V. Tarabichi M, et al. Among authors: craciun l. Mol Cell Endocrinol. 2022 Feb 5;541:111491. doi: 10.1016/j.mce.2021.111491. Epub 2021 Nov 2. Mol Cell Endocrinol. 2022. PMID: 34740746 Review.
97 results